Literature DB >> 15743434

Intestinal prevalence of the neurotropic black yeast Exophiala (Wangiella) dermatitidis in healthy and impaired individuals.

G S de Hoog1, T Matos, M Sudhadham, K F Luijsterburg, G Haase.   

Abstract

A screening of 2300 samples of faeces from humans with and without underlying disease revealed that the black yeast Exophiala dermatitidis is present at a frequency of 5.2 per thousand (n=12). Eight individuals positive for the fungus had diarrhoea at the moment of its isolation, out of 11 where relevant information was available. Judging from repeated isolation over several weeks in one patient, the organism is able to persist in the human intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743434     DOI: 10.1111/j.1439-0507.2004.01083.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  17 in total

Review 1.  Ecology of the Human Opportunistic Black Yeast Exophiala dermatitidis Indicates Preference for Human-Made Habitats.

Authors:  Monika Novak Babič; Jerneja Zupančič; Nina Gunde-Cimerman; Sybren de Hoog; Polona Zalar
Journal:  Mycopathologia       Date:  2017-04-26       Impact factor: 2.574

Review 2.  Catheter-associated fungemia due to Exophiala oligosperma in a leukemic child and review of fungemia cases caused by Exophiala species.

Authors:  I Al-Obaid; S Ahmad; Z U Khan; B Dinesh; H M Hejab
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

Review 3.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Cytolocalization of the class V chitin synthase in the yeast, hyphal and sclerotic morphotypes of Wangiella (Exophiala) dermatitidis.

Authors:  Dariusz Abramczyk; Changwon Park; Paul J Szaniszlo
Journal:  Fungal Genet Biol       Date:  2008-10-21       Impact factor: 3.495

5.  Isolation and antifungal susceptibility of Exophiala dermatitidis isolates from human stool samples in Nigeria.

Authors:  E I Nweze; S Ezute
Journal:  Mycopathologia       Date:  2009-10-17       Impact factor: 2.574

6.  Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection.

Authors:  Fanny Lanternier; Elisa Barbati; Ulrich Meinzer; Luyan Liu; Vincent Pedergnana; Mélanie Migaud; Sébastien Héritier; Maryline Chomton; Marie-Louise Frémond; Emmanuel Gonzales; Caroline Galeotti; Serge Romana; Emmanuel Jacquemin; Adela Angoulvant; Valeska Bidault; Danielle Canioni; Julie Lachenaud; Davood Mansouri; Seyed Alireza Mahdaviani; Parvaneh Adimi; Nahal Mansouri; Mahin Jamshidi; Marie-Elisabeth Bougnoux; Laurent Abel; Olivier Lortholary; Stéphane Blanche; Jean-Laurent Casanova; Capucine Picard; Anne Puel
Journal:  J Infect Dis       Date:  2014-07-23       Impact factor: 5.226

7.  Spectrum of clinically relevant Exophiala species in the United States.

Authors:  J S Zeng; D A Sutton; A W Fothergill; M G Rinaldi; M J Harrak; G S de Hoog
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

8.  Massive contamination of Exophiala dermatitidis and E. phaeomuriformis in railway stations in subtropical Turkey.

Authors:  Aylin Döğen; Engin Kaplan; Macit Ilkit; G Sybren de Hoog
Journal:  Mycopathologia       Date:  2012-11-03       Impact factor: 2.574

9.  WdStuAp, an APSES transcription factor, is a regulator of yeast-hyphal transitions in Wangiella (Exophiala) dermatitidis.

Authors:  Qin Wang; Paul J Szaniszlo
Journal:  Eukaryot Cell       Date:  2007-08-10

Review 10.  Clinical Spectrum, Molecular Characterization, Antifungal Susceptibility Testing of Exophiala spp. From India and Description of a Novel Exophiala Species, E. arunalokei sp. nov.

Authors:  Shreya Singh; Shivaprakash M Rudramurthy; Arvind A Padhye; Basavaraj M Hemashetter; Ranganathan Iyer; Vinaykumar Hallur; Anuradha Sharma; Sourav Agnihotri; Sunita Gupta; Anup Ghosh; Harsimran Kaur
Journal:  Front Cell Infect Microbiol       Date:  2021-07-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.